nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—Procedural pain—Everolimus—kidney cancer	0.0455	0.0634	CcSEcCtD
Fospropofol—Hypoxemia—Gemcitabine—kidney cancer	0.0434	0.0605	CcSEcCtD
Fospropofol—Propofol—CYP1A1—kidney cancer	0.0158	1	CrCbGaD
Fospropofol—Hypoxia—Gemcitabine—kidney cancer	0.0137	0.0191	CcSEcCtD
Fospropofol—Hepatic failure—Pazopanib—kidney cancer	0.0133	0.0185	CcSEcCtD
Fospropofol—Hepatic failure—Everolimus—kidney cancer	0.0105	0.0146	CcSEcCtD
Fospropofol—Hepatic failure—Erlotinib—kidney cancer	0.0101	0.0141	CcSEcCtD
Fospropofol—Hepatic failure—Sorafenib—kidney cancer	0.00912	0.0127	CcSEcCtD
Fospropofol—Tingling sensation—Paclitaxel—kidney cancer	0.00908	0.0127	CcSEcCtD
Fospropofol—Hepatic failure—Sunitinib—kidney cancer	0.00877	0.0122	CcSEcCtD
Fospropofol—Hepatic failure—Dactinomycin—kidney cancer	0.00831	0.0116	CcSEcCtD
Fospropofol—Angiopathy—Temsirolimus—kidney cancer	0.00796	0.0111	CcSEcCtD
Fospropofol—Mediastinal disorder—Temsirolimus—kidney cancer	0.00791	0.011	CcSEcCtD
Fospropofol—Angiopathy—Pazopanib—kidney cancer	0.0075	0.0105	CcSEcCtD
Fospropofol—Mediastinal disorder—Pazopanib—kidney cancer	0.00745	0.0104	CcSEcCtD
Fospropofol—Tingling sensation—Capecitabine—kidney cancer	0.00745	0.0104	CcSEcCtD
Fospropofol—Hepatic failure—Vincristine—kidney cancer	0.00742	0.0103	CcSEcCtD
Fospropofol—Ventricular tachycardia—Paclitaxel—kidney cancer	0.0073	0.0102	CcSEcCtD
Fospropofol—Hepatic failure—Gemcitabine—kidney cancer	0.00704	0.00981	CcSEcCtD
Fospropofol—Cough—Temsirolimus—kidney cancer	0.00667	0.0093	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.00646	0.00901	CcSEcCtD
Fospropofol—Cough—Pazopanib—kidney cancer	0.00628	0.00876	CcSEcCtD
Fospropofol—Nervous system disorder—Temsirolimus—kidney cancer	0.00612	0.00853	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.00609	0.00849	CcSEcCtD
Fospropofol—Skin disorder—Temsirolimus—kidney cancer	0.00606	0.00845	CcSEcCtD
Fospropofol—Angiopathy—Everolimus—kidney cancer	0.00592	0.00826	CcSEcCtD
Fospropofol—Mediastinal disorder—Everolimus—kidney cancer	0.00588	0.0082	CcSEcCtD
Fospropofol—Nervous system disorder—Pazopanib—kidney cancer	0.00576	0.00803	CcSEcCtD
Fospropofol—Skin disorder—Pazopanib—kidney cancer	0.00571	0.00796	CcSEcCtD
Fospropofol—Mediastinal disorder—Erlotinib—kidney cancer	0.00568	0.00792	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00538	0.00751	CcSEcCtD
Fospropofol—Pain—Temsirolimus—kidney cancer	0.00533	0.00744	CcSEcCtD
Fospropofol—Paraesthesia—Pazopanib—kidney cancer	0.00528	0.00736	CcSEcCtD
Fospropofol—Angiopathy—Sorafenib—kidney cancer	0.00514	0.00717	CcSEcCtD
Fospropofol—Mediastinal disorder—Sorafenib—kidney cancer	0.00511	0.00712	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00507	0.00707	CcSEcCtD
Fospropofol—Pain—Pazopanib—kidney cancer	0.00502	0.007	CcSEcCtD
Fospropofol—Cough—Everolimus—kidney cancer	0.00496	0.00692	CcSEcCtD
Fospropofol—Angiopathy—Sunitinib—kidney cancer	0.00495	0.0069	CcSEcCtD
Fospropofol—Mediastinal disorder—Sunitinib—kidney cancer	0.00492	0.00685	CcSEcCtD
Fospropofol—Hepatic failure—Capecitabine—kidney cancer	0.00484	0.00674	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.00481	0.0067	CcSEcCtD
Fospropofol—Cough—Erlotinib—kidney cancer	0.00479	0.00667	CcSEcCtD
Fospropofol—Stinging—Doxorubicin—kidney cancer	0.00476	0.00664	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.00464	0.00646	CcSEcCtD
Fospropofol—Nervous system disorder—Everolimus—kidney cancer	0.00455	0.00634	CcSEcCtD
Fospropofol—Skin disorder—Everolimus—kidney cancer	0.00451	0.00628	CcSEcCtD
Fospropofol—Pruritus—Temsirolimus—kidney cancer	0.00441	0.00615	CcSEcCtD
Fospropofol—Nervous system disorder—Erlotinib—kidney cancer	0.00439	0.00612	CcSEcCtD
Fospropofol—Skin disorder—Erlotinib—kidney cancer	0.00435	0.00606	CcSEcCtD
Fospropofol—Hypotension—Everolimus—kidney cancer	0.00433	0.00604	CcSEcCtD
Fospropofol—Cough—Sorafenib—kidney cancer	0.00431	0.006	CcSEcCtD
Fospropofol—Angiopathy—Vincristine—kidney cancer	0.00419	0.00584	CcSEcCtD
Fospropofol—Paraesthesia—Vinblastine—kidney cancer	0.00418	0.00583	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00417	0.00582	CcSEcCtD
Fospropofol—Paraesthesia—Everolimus—kidney cancer	0.00417	0.00581	CcSEcCtD
Fospropofol—Mediastinal disorder—Vincristine—kidney cancer	0.00416	0.0058	CcSEcCtD
Fospropofol—Pruritus—Pazopanib—kidney cancer	0.00416	0.0058	CcSEcCtD
Fospropofol—Cough—Sunitinib—kidney cancer	0.00414	0.00578	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00401	0.0056	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Everolimus—kidney cancer	0.00401	0.00558	CcSEcCtD
Fospropofol—Pain—Vinblastine—kidney cancer	0.00398	0.00555	CcSEcCtD
Fospropofol—Angiopathy—Gemcitabine—kidney cancer	0.00397	0.00554	CcSEcCtD
Fospropofol—Pain—Everolimus—kidney cancer	0.00397	0.00553	CcSEcCtD
Fospropofol—Vomiting—Temsirolimus—kidney cancer	0.00397	0.00553	CcSEcCtD
Fospropofol—Nervous system disorder—Sorafenib—kidney cancer	0.00395	0.00551	CcSEcCtD
Fospropofol—Mediastinal disorder—Gemcitabine—kidney cancer	0.00394	0.0055	CcSEcCtD
Fospropofol—Skin disorder—Sorafenib—kidney cancer	0.00391	0.00545	CcSEcCtD
Fospropofol—Headache—Temsirolimus—kidney cancer	0.00391	0.00545	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00386	0.00539	CcSEcCtD
Fospropofol—Ventricular tachycardia—Doxorubicin—kidney cancer	0.00386	0.00538	CcSEcCtD
Fospropofol—Pain—Erlotinib—kidney cancer	0.00383	0.00534	CcSEcCtD
Fospropofol—Nervous system disorder—Sunitinib—kidney cancer	0.0038	0.0053	CcSEcCtD
Fospropofol—Skin disorder—Sunitinib—kidney cancer	0.00376	0.00525	CcSEcCtD
Fospropofol—Vomiting—Pazopanib—kidney cancer	0.00374	0.00521	CcSEcCtD
Fospropofol—Nausea—Temsirolimus—kidney cancer	0.0037	0.00516	CcSEcCtD
Fospropofol—Headache—Pazopanib—kidney cancer	0.00368	0.00513	CcSEcCtD
Fospropofol—Nausea—Pazopanib—kidney cancer	0.00349	0.00487	CcSEcCtD
Fospropofol—Paraesthesia—Sunitinib—kidney cancer	0.00348	0.00485	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00348	0.00485	CcSEcCtD
Fospropofol—Pain—Sorafenib—kidney cancer	0.00344	0.0048	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00335	0.00466	CcSEcCtD
Fospropofol—Cough—Gemcitabine—kidney cancer	0.00332	0.00463	CcSEcCtD
Fospropofol—Angiopathy—Paclitaxel—kidney cancer	0.00332	0.00463	CcSEcCtD
Fospropofol—Pain—Sunitinib—kidney cancer	0.00331	0.00462	CcSEcCtD
Fospropofol—Mediastinal disorder—Paclitaxel—kidney cancer	0.0033	0.0046	CcSEcCtD
Fospropofol—Pruritus—Everolimus—kidney cancer	0.00328	0.00458	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00322	0.00449	CcSEcCtD
Fospropofol—Nervous system disorder—Vincristine—kidney cancer	0.00321	0.00448	CcSEcCtD
Fospropofol—Pruritus—Erlotinib—kidney cancer	0.00317	0.00442	CcSEcCtD
Fospropofol—Pain—Dactinomycin—kidney cancer	0.00314	0.00437	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—kidney cancer	0.00312	0.00435	CcSEcCtD
Fospropofol—Hypotension—Vincristine—kidney cancer	0.00306	0.00427	CcSEcCtD
Fospropofol—Nervous system disorder—Gemcitabine—kidney cancer	0.00305	0.00425	CcSEcCtD
Fospropofol—Skin disorder—Gemcitabine—kidney cancer	0.00302	0.00421	CcSEcCtD
Fospropofol—Vomiting—Vinblastine—kidney cancer	0.00296	0.00413	CcSEcCtD
Fospropofol—Vomiting—Everolimus—kidney cancer	0.00295	0.00411	CcSEcCtD
Fospropofol—Paraesthesia—Vincristine—kidney cancer	0.00294	0.0041	CcSEcCtD
Fospropofol—Headache—Vinblastine—kidney cancer	0.00292	0.00407	CcSEcCtD
Fospropofol—Headache—Everolimus—kidney cancer	0.00291	0.00405	CcSEcCtD
Fospropofol—Hypotension—Gemcitabine—kidney cancer	0.00291	0.00405	CcSEcCtD
Fospropofol—Pruritus—Sorafenib—kidney cancer	0.00285	0.00397	CcSEcCtD
Fospropofol—Vomiting—Erlotinib—kidney cancer	0.00285	0.00397	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Vincristine—kidney cancer	0.00283	0.00394	CcSEcCtD
Fospropofol—Headache—Erlotinib—kidney cancer	0.0028	0.00391	CcSEcCtD
Fospropofol—Pain—Vincristine—kidney cancer	0.0028	0.00391	CcSEcCtD
Fospropofol—Paraesthesia—Gemcitabine—kidney cancer	0.00279	0.00389	CcSEcCtD
Fospropofol—Cough—Paclitaxel—kidney cancer	0.00278	0.00388	CcSEcCtD
Fospropofol—Nausea—Vinblastine—kidney cancer	0.00277	0.00386	CcSEcCtD
Fospropofol—Nausea—Everolimus—kidney cancer	0.00276	0.00384	CcSEcCtD
Fospropofol—Pruritus—Sunitinib—kidney cancer	0.00274	0.00382	CcSEcCtD
Fospropofol—Angiopathy—Capecitabine—kidney cancer	0.00273	0.0038	CcSEcCtD
Fospropofol—Mediastinal disorder—Capecitabine—kidney cancer	0.00271	0.00378	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.0027	0.00376	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00268	0.00374	CcSEcCtD
Fospropofol—Pain—Gemcitabine—kidney cancer	0.00266	0.00371	CcSEcCtD
Fospropofol—Nausea—Erlotinib—kidney cancer	0.00266	0.00371	CcSEcCtD
Fospropofol—Vomiting—Sorafenib—kidney cancer	0.00256	0.00357	CcSEcCtD
Fospropofol—Nervous system disorder—Paclitaxel—kidney cancer	0.00255	0.00356	CcSEcCtD
Fospropofol—Skin disorder—Paclitaxel—kidney cancer	0.00253	0.00353	CcSEcCtD
Fospropofol—Headache—Sorafenib—kidney cancer	0.00252	0.00352	CcSEcCtD
Fospropofol—Vomiting—Sunitinib—kidney cancer	0.00246	0.00343	CcSEcCtD
Fospropofol—Hypotension—Paclitaxel—kidney cancer	0.00243	0.00339	CcSEcCtD
Fospropofol—Headache—Sunitinib—kidney cancer	0.00243	0.00338	CcSEcCtD
Fospropofol—Nausea—Sorafenib—kidney cancer	0.00239	0.00333	CcSEcCtD
Fospropofol—Paraesthesia—Paclitaxel—kidney cancer	0.00234	0.00326	CcSEcCtD
Fospropofol—Vomiting—Dactinomycin—kidney cancer	0.00233	0.00325	CcSEcCtD
Fospropofol—Nausea—Sunitinib—kidney cancer	0.0023	0.00321	CcSEcCtD
Fospropofol—Cough—Capecitabine—kidney cancer	0.00228	0.00318	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00225	0.00313	CcSEcCtD
Fospropofol—Pain—Paclitaxel—kidney cancer	0.00223	0.0031	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00221	0.00309	CcSEcCtD
Fospropofol—Pruritus—Gemcitabine—kidney cancer	0.0022	0.00307	CcSEcCtD
Fospropofol—Nausea—Dactinomycin—kidney cancer	0.00218	0.00304	CcSEcCtD
Fospropofol—Nervous system disorder—Capecitabine—kidney cancer	0.00209	0.00292	CcSEcCtD
Fospropofol—Vomiting—Vincristine—kidney cancer	0.00208	0.00291	CcSEcCtD
Fospropofol—Skin disorder—Capecitabine—kidney cancer	0.00207	0.00289	CcSEcCtD
Fospropofol—Headache—Vincristine—kidney cancer	0.00205	0.00286	CcSEcCtD
Fospropofol—Hypotension—Capecitabine—kidney cancer	0.002	0.00278	CcSEcCtD
Fospropofol—Vomiting—Gemcitabine—kidney cancer	0.00198	0.00276	CcSEcCtD
Fospropofol—Headache—Gemcitabine—kidney cancer	0.00195	0.00272	CcSEcCtD
Fospropofol—Nausea—Vincristine—kidney cancer	0.00195	0.00271	CcSEcCtD
Fospropofol—Paraesthesia—Capecitabine—kidney cancer	0.00192	0.00267	CcSEcCtD
Fospropofol—Nausea—Gemcitabine—kidney cancer	0.00185	0.00257	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00184	0.00257	CcSEcCtD
Fospropofol—Pruritus—Paclitaxel—kidney cancer	0.00184	0.00257	CcSEcCtD
Fospropofol—Pain—Capecitabine—kidney cancer	0.00183	0.00255	CcSEcCtD
Fospropofol—Angiopathy—Doxorubicin—kidney cancer	0.00176	0.00245	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—kidney cancer	0.00175	0.00244	CcSEcCtD
Fospropofol—Vomiting—Paclitaxel—kidney cancer	0.00166	0.00231	CcSEcCtD
Fospropofol—Headache—Paclitaxel—kidney cancer	0.00163	0.00227	CcSEcCtD
Fospropofol—Nausea—Paclitaxel—kidney cancer	0.00155	0.00216	CcSEcCtD
Fospropofol—Pruritus—Capecitabine—kidney cancer	0.00151	0.00211	CcSEcCtD
Fospropofol—Cough—Doxorubicin—kidney cancer	0.00147	0.00205	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00143	0.00199	CcSEcCtD
Fospropofol—Vomiting—Capecitabine—kidney cancer	0.00136	0.00189	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—kidney cancer	0.00135	0.00188	CcSEcCtD
Fospropofol—Headache—Capecitabine—kidney cancer	0.00134	0.00187	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—kidney cancer	0.00134	0.00186	CcSEcCtD
Fospropofol—Hypotension—Doxorubicin—kidney cancer	0.00129	0.00179	CcSEcCtD
Fospropofol—Nausea—Capecitabine—kidney cancer	0.00127	0.00177	CcSEcCtD
Fospropofol—Paraesthesia—Doxorubicin—kidney cancer	0.00124	0.00172	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00119	0.00166	CcSEcCtD
Fospropofol—Pain—Doxorubicin—kidney cancer	0.00118	0.00164	CcSEcCtD
Fospropofol—Pruritus—Doxorubicin—kidney cancer	0.000974	0.00136	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—kidney cancer	0.000876	0.00122	CcSEcCtD
Fospropofol—Headache—Doxorubicin—kidney cancer	0.000863	0.0012	CcSEcCtD
Fospropofol—Nausea—Doxorubicin—kidney cancer	0.000818	0.00114	CcSEcCtD
Fospropofol—GABRB3—BDNF signaling pathway—APC—kidney cancer	0.000402	0.00151	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD2—kidney cancer	0.000396	0.00148	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000396	0.00148	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000389	0.00146	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000387	0.00145	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000384	0.00144	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.00038	0.00142	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000379	0.00142	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000377	0.00141	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000377	0.00141	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000377	0.00141	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000376	0.00141	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—BCHE—kidney cancer	0.000375	0.0014	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000371	0.00139	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000368	0.00138	CbGpPWpGaD
Fospropofol—GABRG3—Ion channel transport—RAF1—kidney cancer	0.000366	0.00137	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000365	0.00137	CbGpPWpGaD
Fospropofol—GABRB1—Ion channel transport—RAF1—kidney cancer	0.000361	0.00135	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—RELA—kidney cancer	0.000354	0.00133	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000347	0.0013	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000346	0.00129	CbGpPWpGaD
Fospropofol—GABRA6—Ion channel transport—RAF1—kidney cancer	0.000342	0.00128	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000341	0.00128	CbGpPWpGaD
Fospropofol—GABRA4—Ion channel transport—RAF1—kidney cancer	0.000337	0.00126	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000337	0.00126	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000332	0.00124	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000331	0.00124	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—L1CAM—kidney cancer	0.000329	0.00123	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000325	0.00122	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000325	0.00122	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000323	0.00121	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000317	0.00119	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—RAF1—kidney cancer	0.000316	0.00118	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—RELA—kidney cancer	0.000314	0.00118	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000312	0.00117	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.00031	0.00116	CbGpPWpGaD
Fospropofol—GABRB2—Ion channel transport—RAF1—kidney cancer	0.000308	0.00116	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MTOR—kidney cancer	0.000308	0.00115	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000305	0.00114	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000303	0.00114	CbGpPWpGaD
Fospropofol—GABRA5—Ion channel transport—RAF1—kidney cancer	0.0003	0.00112	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.0003	0.00112	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000298	0.00112	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000296	0.00111	CbGpPWpGaD
Fospropofol—GABRA3—Ion channel transport—RAF1—kidney cancer	0.000294	0.0011	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000293	0.0011	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000291	0.00109	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000291	0.00109	CbGpPWpGaD
Fospropofol—GABRA2—Ion channel transport—RAF1—kidney cancer	0.000289	0.00108	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000289	0.00108	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—RELA—kidney cancer	0.000288	0.00108	CbGpPWpGaD
Fospropofol—GABRB3—Ion channel transport—RAF1—kidney cancer	0.000287	0.00108	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000286	0.00107	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000285	0.00107	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000285	0.00107	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—BRAF—kidney cancer	0.000284	0.00106	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000282	0.00106	CbGpPWpGaD
Fospropofol—GABRG2—Ion channel transport—RAF1—kidney cancer	0.000282	0.00106	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000281	0.00105	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—BRAF—kidney cancer	0.00028	0.00105	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000278	0.00104	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000277	0.00104	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000276	0.00103	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—JUN—kidney cancer	0.000275	0.00103	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CTNNB1—kidney cancer	0.000273	0.00102	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000272	0.00102	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000266	0.000997	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—BRAF—kidney cancer	0.000265	0.000992	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000263	0.000986	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000263	0.000985	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—BRAF—kidney cancer	0.000261	0.00098	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000261	0.000976	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.00026	0.000974	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL2—kidney cancer	0.00026	0.000973	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000253	0.000949	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000249	0.000935	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ANXA2—kidney cancer	0.000249	0.000935	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000249	0.000932	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000249	0.000931	CbGpPWpGaD
Fospropofol—GABRA1—Ion channel transport—RAF1—kidney cancer	0.000247	0.000924	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000244	0.000915	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000243	0.000909	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000242	0.000906	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00024	0.000901	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—BRAF—kidney cancer	0.000239	0.000896	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000238	0.000893	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000238	0.000891	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000237	0.00089	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—RAF1—kidney cancer	0.000237	0.000889	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—RAF1—kidney cancer	0.000234	0.000875	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000233	0.000875	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000233	0.000874	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—BRAF—kidney cancer	0.000232	0.00087	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000232	0.000868	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000231	0.000865	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000229	0.000859	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—RELA—kidney cancer	0.000229	0.000858	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—BRAF—kidney cancer	0.000228	0.000855	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000228	0.000853	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MAPK3—kidney cancer	0.000228	0.000853	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000227	0.00085	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000225	0.000845	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000225	0.000844	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—BRAF—kidney cancer	0.000224	0.00084	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000224	0.00084	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000224	0.000839	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000223	0.000835	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—BRAF—kidney cancer	0.000223	0.000835	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000222	0.000834	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000222	0.000832	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000222	0.000831	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000221	0.00083	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—RAF1—kidney cancer	0.000221	0.000828	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.00022	0.000824	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00022	0.000824	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—BRAF—kidney cancer	0.000219	0.000819	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—RAF1—kidney cancer	0.000218	0.000818	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000217	0.000815	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	0.000217	0.000811	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000216	0.000811	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000216	0.000809	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000216	0.000809	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000216	0.000809	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000212	0.000796	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00021	0.000787	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000209	0.000784	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000208	0.000781	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000207	0.000777	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KCNMA1—kidney cancer	0.000207	0.000774	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.0002	0.00075	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—RAF1—kidney cancer	0.0002	0.000748	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000199	0.000745	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000198	0.000742	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000195	0.000732	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—RAF1—kidney cancer	0.000194	0.000727	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000194	0.000726	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACY1—kidney cancer	0.000193	0.000721	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000192	0.00072	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—BRAF—kidney cancer	0.000191	0.000716	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—RAF1—kidney cancer	0.00019	0.000714	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.00019	0.000712	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00019	0.000711	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—kidney cancer	0.000189	0.000709	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—RAF1—kidney cancer	0.000187	0.000701	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—RAF1—kidney cancer	0.000186	0.000697	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000184	0.000691	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—RAF1—kidney cancer	0.000183	0.000684	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000181	0.000678	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—GRB7—kidney cancer	0.00018	0.000676	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.00018	0.000675	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000179	0.00067	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000178	0.000667	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000177	0.000662	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000174	0.000651	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000174	0.00065	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000171	0.000639	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITPR2—kidney cancer	0.000168	0.000628	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000168	0.000628	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—kidney cancer	0.000167	0.000625	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000166	0.000624	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000164	0.000615	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PDHB—kidney cancer	0.000164	0.000613	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000163	0.000613	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—MAPK1—kidney cancer	0.000163	0.00061	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—MAPK1—kidney cancer	0.00016	0.0006	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—RAF1—kidney cancer	0.00016	0.000598	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CCBL1—kidney cancer	0.000154	0.000577	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000152	0.000568	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—MAPK1—kidney cancer	0.000152	0.000568	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—MAPK1—kidney cancer	0.00015	0.000561	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000143	0.000535	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000139	0.000522	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—MAPK1—kidney cancer	0.000137	0.000513	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPAT—kidney cancer	0.000133	0.0005	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GLIPR1—kidney cancer	0.000133	0.0005	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—MAPK1—kidney cancer	0.000133	0.000499	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000132	0.000494	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—MAPK1—kidney cancer	0.000131	0.00049	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00013	0.000489	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—MAPK1—kidney cancer	0.000128	0.000481	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—MAPK1—kidney cancer	0.000128	0.000478	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000128	0.000478	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000126	0.000471	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—MAPK1—kidney cancer	0.000125	0.000469	CbGpPWpGaD
Fospropofol—ALB—Metabolism—FH—kidney cancer	0.000124	0.000465	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APRT—kidney cancer	0.000124	0.000465	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA1—kidney cancer	0.000123	0.000461	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000121	0.000454	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000119	0.000445	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000117	0.00044	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPC3—kidney cancer	0.000117	0.000437	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA2—kidney cancer	0.000115	0.000429	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000114	0.000427	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CA2—kidney cancer	0.000113	0.000425	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALAD—kidney cancer	0.000111	0.000414	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.00011	0.000413	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00011	0.000412	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—MAPK1—kidney cancer	0.000109	0.00041	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ST3GAL2—kidney cancer	0.000108	0.000404	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000107	0.000402	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDH1A1—kidney cancer	0.000105	0.000395	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000104	0.000391	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF2—kidney cancer	0.000103	0.000386	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000102	0.000384	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC5A3—kidney cancer	0.000101	0.000379	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PGK1—kidney cancer	0.000101	0.000379	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000101	0.000377	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	0.0001	0.000375	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LDHB—kidney cancer	9.92e-05	0.000372	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	9.87e-05	0.00037	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	9.82e-05	0.000368	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.68e-05	0.000325	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CA9—kidney cancer	8.6e-05	0.000322	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.58e-05	0.000322	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.4e-05	0.000315	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	8.39e-05	0.000314	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	7.94e-05	0.000297	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	7.55e-05	0.000283	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CRABP1—kidney cancer	7.31e-05	0.000274	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ITPR2—kidney cancer	6.8e-05	0.000255	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	6.55e-05	0.000246	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.27e-05	0.000235	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTT1—kidney cancer	6.2e-05	0.000232	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACHE—kidney cancer	6.2e-05	0.000232	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SCARB1—kidney cancer	5.87e-05	0.00022	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS1—kidney cancer	5.81e-05	0.000218	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSMD7—kidney cancer	5.7e-05	0.000213	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RAF1—kidney cancer	5.67e-05	0.000213	CbGpPWpGaD
Fospropofol—ALB—Metabolism—BCHE—kidney cancer	5.4e-05	0.000202	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC5A5—kidney cancer	5.33e-05	0.0002	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A1—kidney cancer	5.15e-05	0.000193	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2—kidney cancer	5.09e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5e-05	0.000187	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.91e-05	0.000184	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.36e-05	0.000163	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—kidney cancer	4.32e-05	0.000162	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTP1—kidney cancer	4.3e-05	0.000161	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK3—kidney cancer	4.09e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCB1—kidney cancer	4.07e-05	0.000152	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—kidney cancer	3.95e-05	0.000148	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK1—kidney cancer	3.89e-05	0.000146	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1A1—kidney cancer	3.74e-05	0.00014	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KRAS—kidney cancer	3.68e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CA—kidney cancer	3.38e-05	0.000127	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—kidney cancer	3.27e-05	0.000122	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.07e-05	0.000115	CbGpPWpGaD
Fospropofol—ALB—Metabolism—POMC—kidney cancer	2.79e-05	0.000105	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—kidney cancer	2.23e-05	8.34e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTEN—kidney cancer	1.94e-05	7.27e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CA—kidney cancer	1.37e-05	5.13e-05	CbGpPWpGaD
